De mulige kurene på kreft - Dr. Steve

Tid er penger - En podcast med Peter Warren

Tid er penger har gleden av å ha Dr. Steve som gjest i dagens podcast, der vi får stille mange dumme spørsmål rundt diverse kreftbehandlinger som er under utvikling i dag, som han kan svare på i dybden. Selve episoden er ganske teknisk og han bruker mange kompliserte termer. Vi har laget en oppsummering av det han snakker om under, og gjorde det på engelsk for at det skulle være helt korrekt ref hans ord og uttrykk:

1. *HPV Vaccine*: A preventative vaccine for cervical cancer caused by the human papillomavirus (HPV). It's also effective against other cancers caused by HPV, such as head and neck, rectal, and penile cancers.

2. *Hepatitis B Vaccine*: Mentioned as an anti-cancer vaccine since chronic hepatitis B can lead to liver cancer.

3. *mRNA Technology*: Used in vaccines and treatments, mRNA technology instructs cells to produce proteins that stimulate the immune system to target cancer cells. It's being researched for various cancers, including pancreatic cancer and melanoma.

4. *Immune Therapy (PDL-1 Inhibitors)*: Antibodies created in the laboratory to help the immune system recognize and attack cancer cells, used in a variety of cancers.

5. *CAR-T Cell Therapy (Chimeric Antigen Receptor T-Cell Therapy)*: A treatment where a patient's T cells are engineered to better recognize and attack cancer cells, currently approved for certain blood cancers like lymphomas and leukemias.

6. *Viral Oncolytic Therapy*: Uses viruses, such as the measles virus, to infect and kill cancer cells, particularly being researched for multiple myeloma.

7. *Proton Beam Therapy*: An advanced form of radiation therapy that uses a beam of protons to precisely target and kill cancer cells while sparing surrounding healthy tissue.

8. *Monoclonal Antibodies*: Proteins manufactured in the lab that can target specific antigens on cancer cells, used in various cancers for both treatment and diagnostic purposes.

9. *Tyrosine Kinase Inhibitors*: Targeted therapies that block specific enzymes (tyrosine kinases) involved in the growth and spread of cancer cells.

10. *Research on Universal T-Cell Receptor Targeting Cancer Cells*: Early-stage research into T-cell receptors that can recognize and kill a broad range of cancer types via a specific protein, potentially leading to a more universal cancer treatment.

---

Hosted on Acast. See acast.com/privacy for more information.